Cath Lab Digest

@CathLabDigest · joined 28 Oct 2009

News and clinical updates for the cath lab specialist.

12 186Followers

3 235Following

3 188Posts total

1.7KViews on collected posts

โพสต์ล่าสุด

Cath Lab Digest@CathLabDigest23 Sep

@CathLabDigest Thank you for sharing our news! 3 views · 0 likes · 0 reposts · 0 replies Open on X →

Cath Lab Digest@CathLabDigest21 Sep

The FDA has approved the SELUTION SLR™ PTCA drug-eluting balloon, marking an important milestone for coronary intervention and expanding treatment options for patients. Learn more about the approval: https://t.co/IldXfnhRkH) https://t.co/MXKslTebno

370 views · 3 likes · 0 reposts · 1 replies Open on X →

Cath Lab Digest@CathLabDigest17 Sep

Concomitant LAAC is growing—is your workflow ready? Join Episode 2 of WATCHMAN™ LAAC in Practice for practical insights on scheduling, case optimization, care team alignment, and scalable program design. https://t.co/xxM3knC8Xl https://t.co/JCz6Dyj6Tv

287 views · 1 likes · 0 reposts · 0 replies Open on X →

Cath Lab Digest@CathLabDigest15 Sep

The Ambulatory Surgery Center Association (ASCA) is urging CMS to eliminate the ASC weight scalar, warning that proposed 2027 payment cuts could limit patient access to lower-cost surgery centers. https://t.co/l1nqCuZGOG https://t.co/zmxCZeYHZY

363 views · 2 likes · 0 reposts · 0 replies Open on X →

Cath Lab Digest@CathLabDigest14 Sep

One coordinated case. Two procedures. Considerations for program growth. Learn how strategic scheduling and coordinated pathways can support concomitant LAAC and AF ablation without compromising throughput. Register: https://t.co/Y9i5rBSYkC https://t.co/hxbtiNfjB5

308 views · 0 likes · 0 reposts · 0 replies Open on X →

Cath Lab Digest@CathLabDigest12 Sep

New Supplement: CIED Management 2026 Explore scalable workflows, responsible AI use, and strategies for addressing transmission volumes, staffing constraints, alert fatigue, interoperability gaps, and financial pressures—plus an RFP capability matrix. https://t.co/hzZrN3MRIU]

354 views · 0 likes · 0 reposts · 0 replies Open on X →

เทียบกับบัญชีขนาดเดียวกัน

6 โพสต์จาก 90 วันที่ผ่านมา เทียบกับช่วง 10K–100K ผู้ติดตาม การเข้าถึงปกติสำหรับขนาดนี้ แต่การตอบสนองอ่อนกว่าส่วนใหญ่.

ยอดดูมัธยฐาน331บัญชีนี้924ค่ามัธยฐานของ 10K–100K

การเข้าถึง, %2.72%บัญชีนี้3.62%ค่ามัธยฐานของ 10K–100K

การมีส่วนร่วม, %0.17%บัญชีนี้1.52%ค่ามัธยฐานของ 10K–100K

ตัวชี้วัด	บัญชีนี้	ค่ามัธยฐานของ 10K–100K	อัตราส่วน
ยอดดูมัธยฐานต่อโพสต์	331	924	0.36×
การเข้าถึง (ยอดดู ÷ ผู้ติดตาม)	2.72%	3.62%	0.75×
อัตราการมีส่วนร่วม	0.17%	1.52%	0.11×

บัญชีอื่นในช่วงนี้ → เปรียบเทียบกับบัญชีอื่น → ค่าอ้างอิงเหล่านี้คำนวณอย่างไร →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

35412 Sep

30814 Sep

36315 Sep

28717 Sep

37021 Sep

323 Sep

Last 6 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.00%12 Sep

0.00%14 Sep

0.55%15 Sep

0.35%17 Sep

1.08%21 Sep

0.00%23 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes85.7%6 in total

Replies14.3%1 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.